| Primary |
| Parkinson's Disease |
29.2% |
| Product Used For Unknown Indication |
16.7% |
| Psychotic Disorder |
16.7% |
| Moyamoya Disease |
12.5% |
| Convulsion |
8.3% |
| Extrapyramidal Disorder |
8.3% |
| Dystonia |
4.2% |
| Epilepsy |
4.2% |
|
| Extrapyramidal Disorder |
25.0% |
| Blister |
12.5% |
| Convulsion |
12.5% |
| Drug Interaction |
12.5% |
| Insomnia |
12.5% |
| Myocardial Infarction |
12.5% |
| Stevens-johnson Syndrome |
12.5% |
|
| Secondary |
| Product Used For Unknown Indication |
25.1% |
| Drug Use For Unknown Indication |
17.1% |
| Parkinson's Disease |
13.9% |
| Schizophrenia |
12.4% |
| Parkinsonism |
8.8% |
| Bipolar Disorder |
4.4% |
| Depression |
3.6% |
| Tardive Dyskinesia |
3.2% |
| Akathisia |
2.4% |
| Depressed Mood |
2.4% |
| Hypertension |
1.6% |
| Constipation |
1.2% |
| Bipolar I Disorder |
0.8% |
| Resting Tremor |
0.8% |
| Agitation |
0.4% |
| Dry Mouth |
0.4% |
| Extrapyramidal Disorder |
0.4% |
| Insomnia |
0.4% |
| Pyoderma |
0.4% |
| Trichotillomania |
0.4% |
|
| Restlessness |
15.4% |
| Torticollis |
12.8% |
| Cytolytic Hepatitis |
7.7% |
| Neuroleptic Malignant Syndrome |
7.7% |
| Speech Disorder |
7.7% |
| Abdominal Compartment Syndrome |
5.1% |
| Coronary Artery Dissection |
5.1% |
| Suicidal Ideation |
5.1% |
| Tardive Dyskinesia |
5.1% |
| Agranulocytosis |
2.6% |
| Aphasia |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.6% |
| Dyskinesia Oesophageal |
2.6% |
| Dysphemia |
2.6% |
| Hemiplegia |
2.6% |
| Memory Impairment |
2.6% |
| Mood Swings |
2.6% |
| Overdose |
2.6% |
| Rhabdomyolysis |
2.6% |
|
| Concomitant |
| Schizophrenia |
20.6% |
| Drug Use For Unknown Indication |
13.7% |
| Product Used For Unknown Indication |
11.8% |
| Parkinson's Disease |
7.2% |
| Parkinsonism |
6.2% |
| Psychotic Disorder |
5.4% |
| Depression |
4.6% |
| Epilepsy |
4.3% |
| Schizophrenia, Disorganised Type |
4.3% |
| Insomnia |
3.2% |
| Hallucination |
2.9% |
| Hypertension |
2.1% |
| Tremor |
2.1% |
| Anxiety |
1.9% |
| Constipation |
1.9% |
| Diabetes Mellitus |
1.6% |
| Gastritis |
1.6% |
| Neuropathy |
1.6% |
| Subcutaneous Abscess |
1.6% |
| Bladder Cancer |
1.3% |
|
| Restlessness |
10.0% |
| Wrong Technique In Drug Usage Process |
8.6% |
| Initial Insomnia |
7.1% |
| Extrapyramidal Disorder |
5.7% |
| Pneumonia Aspiration |
5.7% |
| Pyrexia |
5.7% |
| Rhabdomyolysis |
5.7% |
| Urinary Retention |
5.7% |
| Von Willebrand's Disease |
5.7% |
| Cardio-respiratory Arrest |
4.3% |
| Condition Aggravated |
4.3% |
| Diabetes Mellitus |
4.3% |
| Granulocytopenia |
4.3% |
| Somnolence |
4.3% |
| Vomiting |
4.3% |
| Gamma-glutamyltransferase Increased |
2.9% |
| Hip Dysplasia |
2.9% |
| Loss Of Consciousness |
2.9% |
| Mental Disorder |
2.9% |
| Neuroleptic Malignant Syndrome |
2.9% |
|
